Cargando…
An Application of the Patient Rule-Induction Method to Detect Clinically Meaningful Subgroups from Failed Phase III Clinical Trials
BACKGROUND: Phase III superiority clinical trials have negative results (new treatment is not statistically better than standard of care) due to a number of factors, including patient and disease heterogeneity. However, even a treatment regime that fails to show population-level clinical improvement...
Autor principal: | Dyson, Greg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496893/ https://www.ncbi.nlm.nih.gov/pubmed/34632463 http://dx.doi.org/10.23937/2469-5831/1510038 |
Ejemplares similares
-
The Autism Phenome Project: Toward Identifying Clinically Meaningful Subgroups of Autism
por: Nordahl, Christine Wu, et al.
Publicado: (2022) -
Frequentist rules for regulatory approval of subgroups in phase III
trials: A fresh look at an old problem
por: Edgar, K, et al.
Publicado: (2021) -
Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma
por: Koh, Jiwon, et al.
Publicado: (2020) -
Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma
por: Hollis, Robert L., et al.
Publicado: (2019) -
Clinical prediction rules for failed nonoperative reduction of intussusception
por: Khorana, Jiraporn, et al.
Publicado: (2016)